Radial approach reduces mortality in patients with ST-segment elevation myocardial infarction and cardiogenic shock

被引:19
|
作者
Tokarek, Tomasz [1 ,2 ]
Dziewierz, Artur [1 ,3 ]
Plens, Krzysztof [4 ]
Rakowski, Tomasz [1 ,3 ]
Dudek, Dariusz [3 ]
Siudak, Zbigniew [5 ]
机构
[1] Univ Hosp, Dept Cardiol & Cardiovasc Intervent, Ul Jakubowskiego 2, PL-30688 Krakow, Poland
[2] Jagiellonian Univ, Dept Intens Care & Perioperat Med, Med Coll, Krakow, Poland
[3] Jagiellonian Univ, Dept Cardiol 2, Inst Cardiol, Med Coll, Krakow, Poland
[4] KCRI, Krakow, Poland
[5] Jan Kochanowski Univ, Fac Med & Hlth Sci, Kielce, Poland
关键词
cardiogenic shock; femoral approach; mortality; radial approach; registry; PERCUTANEOUS CORONARY INTERVENTION; FEMORAL APPROACH; ARTERIAL ACCESS; METAANALYSIS; ANGIOGRAPHY; EXPERIENCE; OUTCOMES; SUPPORT;
D O I
10.20452/pamw.15886
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
INTRODuCTION The beneficial outcome of the radial approach (RA) over the femoral approach (FA) in ST -segment elevation myocardial infarction (STEMI) has been widely demonstrated. However, most of the studies excluded patients with STEMI and cardiogenic shock (CS). OBjECTIvES We sought to evaluate periprocedural outcomes of percutaneous coronary intervention (PCI) with the RA and FA in patients with STEMI complicated by CS using data from the Polish National PCI Registry (ORPKI). PATIENTS AND METNODS A total of 3565 consecutive patients with STEMI and CS treated with emergent PCI and stent implantation were included. Data were collected prospectively from 151 tertiary invasive cardiology centers performing primary PCI in Poland between 2014 and 2018. To avoid possible selection bias, propensity score matching was used to create 945 matched pairs treated via the RA or FA. RESuLTS No differences were reported in baseline characteristics, clinical presentation, and delays in treatment between the RA and FA after propensity score matching. Similar radiation doses and total amount of contrast were used in both groups. A similar rate of periprocedural complications was observed in both RA and FA. However, the RA was associated with reduced periprocedural mortality (89 [9.4%] vs 176 [18.6%]; P = 0.001) and lower incidence of cardiac arrest (92 [9.7%] vs 152 [16.1%]; P = 0.001). The FA was the strongest independent predictor of increased periprocedural mortality in the multivariable analysis (odds ratio, 2.087; 95% CI, 1.629-2.674; P = 0.001). CONCLuSIONS The RA was associated with lower periprocedural mortality compared with the FA in patients with STEMI complicated by CS. The RA seems to be a valuable option in technically feasible situations.
引用
收藏
页码:421 / 428
页数:8
相关论文
共 50 条
  • [41] ST-segment elevation myocardial infarction
    Vogel, Birgit
    Claessen, Bimmer E.
    Arnold, Suzanne, V
    Chan, Danny
    Cohen, David J.
    Giannitsis, Evangelos
    Gibson, C. Michael
    Coto, Shinya
    Katus, Hugo A.
    Kerneis, Mathieu
    Kimura, Takeshi
    Kunadian, Vijay
    Pinto, Duane S.
    Shiomi, Hiroki
    Spertus, John A.
    Steg, P. Gabriel
    Mehran, Roxana
    NATURE REVIEWS DISEASE PRIMERS, 2019, 5 (1)
  • [42] ST-Segment Elevation Myocardial Infarction
    Younis, George A.
    TEXAS HEART INSTITUTE JOURNAL, 2022, 49 (05) : 111 - 111
  • [44] Bivalirudin in patients with ST-segment elevation myocardial infarction
    Coughlan, J. J.
    Kastrati, Adnan
    LANCET, 2022, 400 (10366): : 1822 - 1823
  • [45] ST-segment elevation myocardial infarction with refractory cardiogenic shock due to coronary spasm: a case report
    Renziehausen, Stephan
    Stoebe, Stephan
    Spies, Christian
    Metze, Michael
    EUROPEAN HEART JOURNAL-CASE REPORTS, 2024, 8 (10)
  • [46] Transradial Artery Access in Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction and Cardiogenic Shock
    Schoenfeld M.S.
    Kassas I.
    Shah B.
    Current Treatment Options in Cardiovascular Medicine, 2018, 20 (2)
  • [47] Palliative care referral in ST-segment elevation myocardial infarction complicated with cardiogenic shock in the United States
    Ando, Tomo
    Akintoye, Emmanuel
    Uemura, Takeshi
    Adegbala, Oluwole
    Ashraf, Said
    Pahuja, Mohit
    Shokr, Mohamed
    Takagi, Hisato
    Grines, Cindy L.
    Afonso, Luis
    Briasoulis, Alexandros
    HEART & LUNG, 2020, 49 (01): : 25 - 29
  • [48] BivalirudinIn Patients with ST-Segment Elevation Myocardial Infarction
    Monique P. Curran
    Drugs, 2010, 70 : 909 - 918
  • [49] Bivalirudin In Patients with ST-Segment Elevation Myocardial Infarction
    Curran, Monique P.
    DRUGS, 2010, 70 (07) : 909 - 918
  • [50] Circulating microparticles and clinical outcomes in persistent ST-segment elevation myocardial infarction complicated with cardiogenic shock
    Sionis, A.
    Suades, R.
    Rosello, J. Sans
    Sanchez-Martinez, M.
    Crespo, J.
    Cubedo, J.
    Ferrero-Gregori, A.
    Vila, M.
    Duran-Cambra, A.
    Badimon, L.
    EUROPEAN HEART JOURNAL, 2016, 37 : 778 - 778